Terms ending in 2038
Every in-force patent on DCB-USA LLC's record whose computed term ends in 2038, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 11,202,854 | Disintegrin Variants and Uses Thereof In force · High confidence | National Taiwan University, National Cheng Kung University and DCB-USA LLC | In force | High confidence | |
| US 11,384,150 | Antibody-Drug Conjugates and Uses Thereof In force · High confidence | Development Center for Biotechnology and Tunghai University | In force | High confidence | |
| US 11,142,567 | Anti-Dengue Virus Antibody, Pharmaceutical Composition Comprising the Same, and Uses Thereof In force · High confidence | National Cheng Kung University and DCB-USA LLC | In force | High confidence |
3 of 3 patents shown. Soonest term end first, then patent number.
2 of these are in force and held by DCB-USA LLC.
Updated Nov 19, 2026 · includes USPTO assignment data published Nov 18, 2026, status data published Nov 19, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.